Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF inhibitors: 52-week Results from a Phase 3 Study

Genovese, M, Helliwell, P, Combe, B et al. (6 more authors) (2018) Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF inhibitors: 52-week Results from a Phase 3 Study. In: Journal of Rheumatology. 73rd Annual Meeting of The Canadian-Rheumatology-Association (CRA), 21-24 Feb 2018, Vancouver, Canada. Journal of Rheumatology Publishing Co., Ltd. , p. 996.

Metadata

Authors/Creators:
  • Genovese, M
  • Helliwell, P
  • Combe, B
  • Kremer, J
  • Adams, D
  • Lee, C
  • Kerr, L
  • Nash, P
  • Rahman, P
Dates:
  • Published: 1 July 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Sep 2018 14:16
Last Modified: 07 Sep 2018 08:59
Status: Published
Publisher: Journal of Rheumatology Publishing Co., Ltd.
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export